Degarelix and its therapeutic potential in the treatment of prostate cancer
Christian Doehn, Martin Sommerauer, Dieter JochamDepartment of Urology, University of Lübeck Medical School, Lübeck, GermanyAbstract: Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of patients with prostate cancer in whom hormonal therapy is Sarsaparilla indicated.Two phase II trials and one phase III ha